Similar Outcomes for Rural, Urban Cancer Patients in SWOG Trials

Share this content:
Similar Outcomes for Rural, Urban Cancer Patients in SWOG Trials
Similar Outcomes for Rural, Urban Cancer Patients in SWOG Trials

WEDNESDAY, Aug. 22, 2018 (HealthDay News) -- Rural and urban cancer patients with uniform care access through participation in a SWOG (formerly the Southwest Oncology Group) treatment trial have similar outcomes, according to a study published online Aug. 17 in JAMA Network Open.

Joseph M. Unger, Ph.D., from SWOG Statistics and Data Management Center in Seattle, and colleagues conducted a comparative effectiveness retrospective cohort analysis involving 36,995 cancer patients from all 50 states enrolled in 44 phase 3 and phase 2/3 SWOG treatment trials. Geographic distribution and survival outcomes were compared for rural versus urban patients.

A total of 19.4 percent of the patients were from rural locations. The researchers found that rural patients were more likely to be aged 65 years or older, were less likely to be black, were similar with respect to sex, and were well-represented within major U.S. geographic regions. Similar clinical prognostic factors were observed. Significantly worse overall and cancer-specific survival was seen for rural patients with adjuvant-stage estrogen receptor-negative and progesterone receptor-negative breast cancer (hazard ratios, 1.27 and 1.26, respectively) in multivariable regression. There were no other statistically significant differences for overall, progression-free, or cancer-specific survival. Regardless of the definition of "rurality," the results were similar.

"This finding suggests that improving access to uniform treatment strategies for patients with cancer may help resolve the disparity in cancer outcomes between rural and urban patients," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Quick New Ebola Test Approved by FDA

Quick New Ebola Test Approved by FDA

Administration authorizes emergency use of first Ebola fingerstick test with portable reader

CDC: Gun Deaths on the Rise in the United States

CDC: Gun Deaths on the Rise in the ...

U.S. has world's highest rate of gun ownership by civilians among industrialized countries

FDA to Ban Most Flavored Electronic Cigarettes

FDA to Ban Most Flavored Electronic Cigarettes

Details of the ban expected to be announced next week

is free, fast, and customized just for you!




Already a member?

Sign In Now »